Powering biotech
innovation across borders
Tadpole Bio provides integrated advisory services across commercialisation, business development, R&D collaboration, and cross-border market entry—helping innovators navigate complex regulatory environments and progress confidently through every stage of the biotech lifecycle.
Built to support your journey
Tadpole Bio is a life sciences commercialisation consultancy dedicated to helping global biotech and biopharmaceutical companies establish and thrive in Australia’s world-class R&D ecosystem.
We specialise in early-stage commercialisation, regulatory and compliance guidance, business development, and cross-border collaboration—particularly between Australia and China.
With more than 20 years of industry experience, we provide trusted strategic support to innovators seeking to navigate the complex scientific, commercial, and regulatory pathways that bring new technologies to market.
Our mission in action
To accelerate global biotechnology innovation by providing high-integrity advisory, commercialisation expertise, and strategic partnerships that enable companies to confidently enter and operate in Australia.
Our Vision
Tadpole is dedicated to promoting Sino-Australian collaboration through active participation in conferences and innovation competitions in both Australia and China.
Dr. Qiao is a seasoned presenter, adjudicator, public speaker, and chair at various local and international conferences and events in Australia and China
OUR CLIENTS
Tadpole has proudly supported various international biotech and biopharmaceutical companies in establishing subsidiaries in Australia to conduct preclinical and clinical R&D.
Let’s Work Together
Whether you’re exploring an Australian subsidiary, planning a preclinical program, or navigating regulatory pathways, Tadpole Bio offers tailored strategic support to help your innovation succeed.